Annual report

Period2021-10-01 → 2022-03-31
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥19.5bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥186m2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥190m2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥534m2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥292m2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥292m2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥14.2bnat 2022-03-31Cons.Assets
Total liabilities¥11.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2021-09-30Cons.Net assets
Cash and deposits¥1.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥691mat 2021-09-30Cons.Cash and cash equivalents
Operating cash flow¥919m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.5bn2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥2.0bn2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥117.492021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥116.612021-10-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥1,287.13at 2022-03-31Cons.Net assets per share (5-year summary)
Equity ratio22.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
ROE9.4%2021-10-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
Employees1,752at 2022-03-31Cons.Number of employees
Revenue¥116m2021-10-01 → 2022-03-31StandaloneOperating revenue1
Operating income¥52m2021-10-01 → 2022-03-31StandaloneOperating income
Ordinary income¥52m2021-10-01 → 2022-03-31StandaloneOrdinary income
Profit before tax¥52m2021-10-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥62m2021-10-01 → 2022-03-31StandaloneProfit loss
Total assets¥3.1bnat 2022-03-31StandaloneAssets
Total liabilities¥71mat 2022-03-31StandaloneLiabilities
Net assets / equity¥3.1bnat 2022-03-31StandaloneNet assets
Cash and deposits¥3mat 2022-03-31StandaloneCash and deposits
EPS (basic)¥24.862021-10-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥24.682021-10-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥172021-10-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Net assets per share¥1,232.94at 2022-03-31StandaloneNet assets per share (5-year summary)
Equity ratio97.7%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
ROE2.0%2021-10-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
Shares issued2,488,300at 2022-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2021-10-01 → 2022-03-31¥237,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-10-01 → 2022-03-31¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-3122 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-10-01 → 2022-03-31¥932m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-10-01 → 2022-03-31¥905m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-10-01 → 2022-03-31¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥165m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-10-01 → 2022-03-31¥39m
Reconciling Itemsreconcilingcapex2021-10-01 → 2022-03-31¥218m
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-03-31¥42m
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-03-31−¥27m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-03-31−¥27m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥2.0bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-03-31−¥798m
Medicine Businessreportable segmentcapex2021-10-01 → 2022-03-31¥175m
Medicine Businessreportable segmentdepreciation2021-10-01 → 2022-03-31¥68m
Medicine Businessreportable segmentemployeesat 2022-03-31194 pure
Medicine Businessreportable segmentrevenue2021-10-01 → 2022-03-31¥8.8bn
Medicine Businessreportable segmentrevenue external2021-10-01 → 2022-03-31¥8.8bn
Medicine Businessreportable segmentsegment assetsat 2022-03-31¥2.9bn
Medicine Businessreportable segmentsegment profit2021-10-01 → 2022-03-31¥559m
Nursing Care Businessreportable segmentcapex2021-10-01 → 2022-03-31¥69m
Nursing Care Businessreportable segmentdepreciation2021-10-01 → 2022-03-31¥55m
Nursing Care Businessreportable segmentemployeesat 2022-03-31290 pure
Nursing Care Businessreportable segmentrevenue2021-10-01 → 2022-03-31¥3.4bn
Nursing Care Businessreportable segmentrevenue external2021-10-01 → 2022-03-31¥3.4bn
Nursing Care Businessreportable segmentsegment assetsat 2022-03-31¥1.2bn
Nursing Care Businessreportable segmentsegment profit2021-10-01 → 2022-03-31¥25m
Nurturing Businessreportable segmentcapex2021-10-01 → 2022-03-31¥2.6bn
Nurturing Businessreportable segmentdepreciation2021-10-01 → 2022-03-31¥307m
Nurturing Businessreportable segmentemployeesat 2022-03-311192 pure
Nurturing Businessreportable segmentrevenue2021-10-01 → 2022-03-31¥6.4bn
Nurturing Businessreportable segmentrevenue external2021-10-01 → 2022-03-31¥6.4bn
Nurturing Businessreportable segmentsegment assetsat 2022-03-31¥7.8bn
Nurturing Businessreportable segmentsegment profit2021-10-01 → 2022-03-31¥362m
—segment totalcapex2021-10-01 → 2022-03-31¥2.9bn
—segment totaldepreciation2021-10-01 → 2022-03-31¥430m
—segment totalrevenue2021-10-01 → 2022-03-31¥18.6bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥18.6bn
—segment totalsegment assetsat 2022-03-31¥12.0bn
—segment totalsegment profit2021-10-01 → 2022-03-31¥946m
Total Of Reportable Segments And Otherssegment totalcapex2021-10-01 → 2022-03-31¥2.9bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-10-01 → 2022-03-31¥434m
Total Of Reportable Segments And Otherssegment totalrevenue2021-10-01 → 2022-03-31¥19.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-10-01 → 2022-03-31¥19.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-10-01 → 2022-03-31¥27m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥12.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-10-01 → 2022-03-31¥985m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 794
ItemContextValueUnit
Subsidy income on facilities eiCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember442841000JPY
Subsidy income on facilities eiCurrentYearDuration_ReconcilingItemsMember449000JPY
Subsidy income on facilities eiCurrentYearDuration443291000JPY
Impairment loss elCurrentYearDuration_jpcrp030000-asr_E36714-000MedicineBusinessReportableSegmentMember-JPY
Impairment loss elCurrentYearDuration_jpcrp030000-asr_E36714-000NursingCareBusinessReportableSegmentMember50177000JPY
Impairment loss elCurrentYearDuration_jpcrp030000-asr_E36714-000NurturingBusinessReportableSegmentMember6850000JPY
Impairment loss elCurrentYearDuration_ReportableSegmentsMember57027000JPY
Impairment loss elCurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Impairment loss elCurrentYearDuration_UnallocatedAmountsAndEliminationMember56683000JPY
Impairment loss elCurrentYearDuration113711000JPY
GoodwillCurrentYearInstant_jpcrp030000-asr_E36714-000MedicineBusinessReportableSegmentMember-JPY
GoodwillCurrentYearInstant_jpcrp030000-asr_E36714-000NursingCareBusinessReportableSegmentMember-JPY
GoodwillCurrentYearInstant_jpcrp030000-asr_E36714-000NurturingBusinessReportableSegmentMember351691000JPY
GoodwillCurrentYearInstant_ReportableSegmentsMember351691000JPY
GoodwillCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
GoodwillCurrentYearInstant_UnallocatedAmountsAndEliminationMember-JPY
GoodwillCurrentYearInstant351691000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember2619000JPY
Accounts receivable otherCurrentYearInstant_NonConsolidatedMember106267000JPY
Other caCurrentYearInstant_NonConsolidatedMember14484000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember123370000JPY
Stocks of subsidiaries and affiliatesCurrentYearInstant_NonConsolidatedMember3005123000JPY
Deferred tax liabilities allowance investments and other assetsCurrentYearInstant_NonConsolidatedMember10117000JPY
Investments and other assetsCurrentYearInstant_NonConsolidatedMember3015241000JPY
Noncurrent assetsCurrentYearInstant_NonConsolidatedMember3015241000JPY
AssetsCurrentYearInstant_NonConsolidatedMember3138611000JPY
Short term loans payableCurrentYearInstant_NonConsolidatedMember40300000JPY
Accounts payable otherCurrentYearInstant_NonConsolidatedMember27212000JPY
Income taxes payableCurrentYearInstant_NonConsolidatedMember1688000JPY
Other clCurrentYearInstant_NonConsolidatedMember1546000JPY
Current liabilitiesCurrentYearInstant_NonConsolidatedMember70746000JPY
LiabilitiesCurrentYearInstant_NonConsolidatedMember70746000JPY
Capital stockCurrentYearInstant_NonConsolidatedMember300550000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember550000JPY
Other capital surplusCurrentYearInstant_NonConsolidatedMember2705123000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember2705673000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember61704000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember61704000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-63000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember3067865000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember3067865000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember3138611000JPY
Trademark fee income rev oaCurrentYearDuration_NonConsolidatedMember46262000JPY
Dividends from subsidiaries and affiliates rev oaCurrentYearDuration_NonConsolidatedMember69588000JPY
Operating revenue1CurrentYearDuration_NonConsolidatedMember115850000JPY
Operating expensesCurrentYearDuration_NonConsolidatedMember63787000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember52063000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember0JPY
Other noiCurrentYearDuration_NonConsolidatedMember0JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass